 [2007-1-1]Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer |
| [2007-1-1]Electrical Impedance Scanning for the Early Detection of Breast Cancer in Young Women: Preliminary Results of a Multicenter Prospective Clin |
| [2007-1-1]Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Proto |
| [2007-1-1]Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Yea |
| [2007-1-1]Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative |
| [2007-1-1]Risk Factors and Individual Probabilities of Melanoma for Whites |
| [2007-1-1]Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease |
| [2007-1-1]Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan |
| [2007-1-1]Infectious Complications of Central Venous Catheters Increase the Risk of Catheter-Related Thrombosis in Hematology Patients: A Prospective |
| [2007-1-1]Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan |
| [2007-1-1]Late Referrals to Specialized Palliative Care Service in Japan |
| [2007-1-1]Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia |
| [2007-1-1]Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SI |
| [2007-1-1]Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy |
| [2007-1-1]Weekly Epoetin Alfa Maintains Hemoglobin, Improves Quality of Life, and Reduces Transfusion in Breast Cancer Patients Receiving Chemotherapy |
| [2007-1-1]COX-2: A Molecular Target for Colorectal Cancer Prevention |
| [2007-1-1]Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Pati |
| [2007-1-1]Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer |
| [2007-1-1]Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epider |
| [2007-1-1]Effectiveness of Physical Activity on Cardiorespiratory Fitness and Health-Related Quality of Life in Young and Middle-Aged Cancer Patients |
| [2007-1-1]Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme |
| [2007-1-1]Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study |
| [2007-1-1]Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor |
| [2007-1-1]Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Me |
| [2007-1-1]Prognostic Role of Interleukin-1 Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer |
| [2007-1-1]Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial |
| [2007-1-1]Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of |
| [2007-1-1]Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer |
| [2007-1-1]Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution |
| [2007-1-1]Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus |
| [2007-1-1]Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma |
| [2007-1-1]Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up |
| [2007-1-1]Serial Evaluation of Academic and Behavioral Outcome After Treatment With Cranial Radiation in Childhood |
| [2007-1-1]Prognostic Significance of Allelic Imbalance at the c-kit Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarc |
| [2007-1-1]Early Responses to Chemotherapy of Normal and Malignant Hematologic Cells Are Prognostic in Children With Acute Lymphoblastic Leukemia |
| [2007-1-1]Concurrent Administration of High-Dose Rituximab Before and After Autologous Stem-Cell Transplantation for Relapsed Aggressive B-Cell Non-Ho |
| [2007-1-1]Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis From the International Primary CNS Lymphoma Collaborative Group |
| [2007-1-1]Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera |
| [2007-1-1]Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma |
| [2007-1-1]Increasing Incidence of Late Second Malignancies After Conditioning With Cyclophosphamide and Total-Body Irradiation and Autologous Bone Mar |
| [2007-1-1]Improving Accrual of Older Persons to Cancer Treatment Trials: A Randomized Trial Comparing an Educational Intervention With Standard Inform |
| [2007-1-1]Patients With an Unclassified Genetic Variant in the BRCA1 or BRCA2 Genes Show Different Clinical Features From Those With a Mutation |
| [2007-1-1]Postoperative Adjuvant Therapy With Tamoxifen, Tegafur Plus Uracil, or Both in Women With Node-Negative Breast Cancer: A Pooled Analysis of |
| [2007-1-1]Prospective, Randomized Comparison of High-Dose Chemotherapy With Stem-Cell Support Versus Intermediate-Dose Chemotherapy After Surgery and |
| [2007-1-1]Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiatio |
| [2007-1-1]Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule |
| [2007-1-1]Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women |
| [2007-1-1]Randomized Phase II Study of Two Gemcitabine Schedules for Patients With Impaired Performance Status (Karnofsky performance status 70) and |
| [2007-1-1]The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy |
| [2007-1-1]Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboemb |
| [2007-1-1]Study of Anxiety Disorder and Depression in Long-Term Survivors of Testicular Cancer |
| [2007-1-1]Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma |
| [2007-1-1]Couples Who Get Closer After Breast Cancer: Frequency and Predictors in a Prospective Investigation |
| [2007-1-1]Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic |
| [2007-1-1]Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma |
| [2007-1-1]Home-Based Physical Activity Intervention for Breast Cancer Patients |
| [2007-1-1]Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An |
| [2007-1-1]Patient Online Self-Reporting of Toxicity Symptoms During Chemotherapy |
| [2007-1-1]Clinical Value of Mitochondrial Mutations in Colorectal Cancer |
| [2007-1-1]Molecular Determinants of Cetuximab Efficacy |
| [2007-1-1]Molecular Staging for Survival Prediction of Colorectal Cancer Patients |
| [2007-1-1]Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of |
| [2007-1-1]Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer |
| [2007-1-1]Phase II Study of a Liposome-Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally and Pathologic Response Rates in Patients With |
| [2007-1-1]Phase II Study of Irinotecan Plus Cisplatin Induction Followed by Concurrent Twice-Daily Thoracic Irradiation With Etoposide Plus Cisplatin |
| [2007-1-1]Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non–Small-Cell Lung |
| [2007-1-1]Clinical Examination Following Preoperative Chemoradiation for Rectal Cancer Is Not a Reliable Surrogate End Point |
| [2007-1-1]Phase I Study of Hepatic Arterial Melphalan Infusion and Hepatic Venous Hemofiltration Using Percutaneously Placed Catheters in Patients Wit |
| [2007-1-1]Randomized Comparison of Group Versus Individual Genetic Education and Counseling for Familial Breast and/or Ovarian Cancer |
| [2007-1-1]Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse |
| [2007-1-1]Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older |
| [2007-1-1]Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic Leukemia |
| [2007-1-1]Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Pha |
| [2007-1-1]Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies |
| [2007-1-1]International Staging System for Multiple Myeloma |
| [2007-1-1]Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharma |
| [2007-1-1]The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry |
| [2007-1-1]Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Ly |
| [2007-1-1]Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’ |
| [2007-1-1]Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression |
